Anne-Sofie Furberg Selected Research

N-(4-ethoxybenzylidene)-4-butylaniline

8/2015	Alcohol consumption, endogenous estrogen and mammographic density among premenopausal women.
6/2015	High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women.
3/2009	Influence of birth weight and adult body composition on 17beta-estradiol levels in young women.
6/2008	Physical activity, heart rate, metabolic profile, and estradiol in premenopausal women.
6/2007	Low high-density lipoprotein cholesterol may signal breast cancer risk: recent findings and new hypotheses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne-Sofie Furberg Research Topics

Disease

12	Breast Neoplasms (Breast Cancer) 01/2016 - 08/2004
5	Overweight 03/2017 - 05/2003
3	Insulin Resistance 01/2022 - 06/2008
3	Obesity 01/2021 - 05/2003
3	Hypertension (High Blood Pressure) 01/2021 - 05/2003
3	Birth Weight (Birth Weights) 12/2017 - 03/2009
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 06/2008 - 08/2004
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2022 - 03/2017
2	Pain (Aches) 01/2020 - 01/2017
2	Inflammation (Inflammations) 01/2020 - 01/2017
1	Communicable Diseases (Infectious Diseases) 01/2022
1	Dyslipidemias (Dyslipidemia) 01/2021
1	Isolated Systolic Hypertension 01/2021
1	Osteoporosis 01/2021
1	Hypersensitivity (Allergy) 01/2019
1	Asthma (Bronchial Asthma) 01/2019
1	Weight Gain 03/2017
1	Noncommunicable Diseases 01/2017
1	Neoplasms (Cancer) 01/2017
1	Chronic Pain 01/2017
1	Infections 11/2012
1	Carcinogenesis 05/2009
1	Body Weight (Weight, Body) 03/2009
1	Glucose Intolerance 08/2004
1	Chronic Disease (Chronic Diseases) 05/2003
1	Endometrial Neoplasms (Endometrial Cancer) 05/2003

Drug/Important Bio-Agent (IBA)

6	HDL CholesterolIBA 06/2015 - 08/2004
5	Estrogens (Estrogen)FDA Link 01/2016 - 01/2005
5	N-(4-ethoxybenzylidene)-4-butylanilineIBA 08/2015 - 06/2007
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2005
3	Hormones (Hormone)IBA 01/2017 - 01/2005
3	Progesterone FDA LinkGeneric 01/2016 - 05/2012
3	Biological ProductsIBA 06/2015 - 06/2008
3	Triglycerides (Triacylglycerol)IBA 05/2012 - 08/2004
2	perflexane (perfluorohexane)FDA Link 01/2021 - 01/2019
2	MineralsIBA 01/2021 - 12/2017
2	CholesterolIBA 05/2012 - 06/2008
2	LipidsIBA 06/2010 - 06/2008
2	Insulin (Novolin)FDA Link 05/2009 - 06/2008
2	Estradiol (Delestrogen)FDA LinkGeneric 03/2009 - 01/2005
2	Glucose (Dextrose)FDA LinkGeneric 06/2008 - 05/2003
1	Thyroid HormonesIBA 01/2022
1	MicroRNAs (MicroRNA)IBA 01/2022
1	Messenger RNA (mRNA)IBA 01/2022
1	ApolipoproteinsIBA 01/2021
1	perfluorooctanoic acidIBA 01/2021
1	perfluoroheptanesulfonic acidIBA 01/2021
1	oxidized low density lipoproteinIBA 01/2021
1	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 01/2020
1	perfluorooctaneIBA 01/2019
1	Environmental Pollutants (Pollutants, Environmental)IBA 01/2019
1	NickelIBA 01/2019
1	Polysorbates (PSML)FDA Link 03/2017
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2017
1	C-Reactive ProteinIBA 01/2017
1	Gonadal Steroid Hormones (Sex Hormones)IBA 01/2017
1	AndrogensIBA 08/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 07/2014
1	Steroid 17-alpha-Hydroxylase (17 alpha Hydroxylase)IBA 05/2012
1	Pregnancy-Associated Plasma Protein-A (PAPP-A)IBA 01/2012

Therapy/Procedure

1	Condoms (Condom) 11/2012